2019
DOI: 10.1002/1878-0261.12434
|View full text |Cite
|
Sign up to set email alerts
|

High affinity binding of H3K14ac through collaboration of bromodomains 2, 4 and 5 is critical for the molecular and tumor suppressor functions of PBRM1

Abstract: Polybromo‐1 ( PBRM 1) is an important tumor suppressor in kidney cancer. It contains six tandem bromodomains ( BD s), which are specialized structures that recognize acetyl‐lysine residues. While BD 2 has been found to bind acetylated histone H3 lysine 14 (H3K14ac), it is not known whether other BD s collaborate with BD 2 to generate strong binding to H3K14ac, and the importance of H3K14ac recogni… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

3
35
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 22 publications
(38 citation statements)
references
References 36 publications
3
35
0
Order By: Relevance
“…The expression analysis of a set of genes that are repressed by BAZ2A and frequently silenced in advanced and poorly differentiated tumors relative to indolent tumors showed the requirement of EP300, one of the writers of H3K14ac. The link of H3K14ac with gene silencing is also consistent with previous studies showing that the transcription regulator ZMYND8, the tumor suppressor PBRM1, and H3K9 methyltransferase SETDB1 can recognize H3K14ac and repress gene transcription (Jurkowska et al, 2017; Li et al, 2016; Liao et al, 2019). The interaction of BAZ2A-BRD with H3K14ac is also of particular interest since H3K14ac was found to be the most prominent histone modification in regulating SNF2H/ISWI nucleosome remodeling and activating only the NoRC complex (Dann et al, 2017).…”
Section: Discussionsupporting
confidence: 90%
“…The expression analysis of a set of genes that are repressed by BAZ2A and frequently silenced in advanced and poorly differentiated tumors relative to indolent tumors showed the requirement of EP300, one of the writers of H3K14ac. The link of H3K14ac with gene silencing is also consistent with previous studies showing that the transcription regulator ZMYND8, the tumor suppressor PBRM1, and H3K9 methyltransferase SETDB1 can recognize H3K14ac and repress gene transcription (Jurkowska et al, 2017; Li et al, 2016; Liao et al, 2019). The interaction of BAZ2A-BRD with H3K14ac is also of particular interest since H3K14ac was found to be the most prominent histone modification in regulating SNF2H/ISWI nucleosome remodeling and activating only the NoRC complex (Dann et al, 2017).…”
Section: Discussionsupporting
confidence: 90%
“…This result supports the 'histone code' hypothesis and suggests that different combinations of acetylation sites on the p53 CTD can fine-tune p53 transcriptional activity; 3. In agreement with previous report on BD2 and H3K14Ac, 6 adjacent BD(s) collaborates with BD4 to create strong binding to p53 K382Ac. Thus the different BDs might work together like fingers to recognize different KAcs.…”
supporting
confidence: 93%
“…It is also called BAF180, and it targets a SWItch/Sucrose Non-Fermentable (SWI/SNF) chromatin remodeler complex to the chromatins though recognizing acetylated lysine 14 on histone H3 (H3K14Ac) via its BD2. 5,6 The components of the SWI/SNF complex have an overall 20% mutation rate in cancers, making it the second most highly mutated entity next to p53. SWI/SNF mutations are also mutually exclusive with TP53 mutations in many cancer types.…”
mentioning
confidence: 99%
“…Interestingly, one BD, BD2, exclusively interacts with H3K14Ac rather than with other histone lysines. BD2 possesses a highly conserved asparagine at position 263 in the aminoacid sequence (Asn263), which seems to be crucial for acetyl-lysine recognition through hydrogen bond formation to acetyl groups [95,96].…”
Section: Histone 3 Modifications As Biomarkers Of Cancer Progressionmentioning
confidence: 99%